Inovio Pharmaceuticals, Inc. (INO): R&D Expense
$54.21M
Year ended 2025-12-31
$48.49M
Trailing 12 months to 2026-06-30
-33.9%
3-year compound annual growth
-10.5%
5-year compound annual growth
-0.6%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $54.21M | -28.3% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | $75.62M | -12.8% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | $86.68M | -53.8% | 2025-03-18, From 2023-01-01 |
| 2022-12-31 | $187.65M | -24.7% | 2024-03-06, From 2022-01-01 |
| 2021-12-31 | $249.24M | +164.5% | 2024-03-06, From 2021-01-01 |
| 2020-12-31 | $94.25M | +7.1% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $88.02M | -7.6% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $95.26M | -3.4% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $98.57M | +11.1% | 2020-03-12, From 2017-01-01 |
| 2016-12-31 | $88.71M | +53.5% | 2019-03-12, From 2016-01-01 |
| 2015-12-31 | $57.79M | +69.5% | 2018-03-14, From 2015-01-01 |
| 2014-12-31 | $34.10M | +59.6% | 2017-03-15, From 2014-01-01 |
| 2013-12-31 | $21.37M | +18.8% | 2016-03-14, From 2013-01-01 |
| 2012-12-31 | $17.98M | -10.2% | 2015-03-16, From 2012-01-01 |
| 2011-12-31 | $20.03M | +51.1% | 2014-03-17, From 2011-01-01 |
| 2010-12-31 | $13.26M | +40.9% | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | $9.41M | n/a | 2012-03-15, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $54.21M | -28.3% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $37.80M | +29.2% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $2.16M | -8.8% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $50.08M | +105.0% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $5.44M | -14.8% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $10.75M | -16.6% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $21.12M | -29.7% |
| iBio, Inc. (IBIO) | 2026-06-30 | $19.64M | +136.3% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $66.43M | -19.2% |
Compare INO, CNTB, SILO, AVTX side by side · Screen every company in Pharmaceutical Preparations ↗